EX
EXETF.US Extendicare Inc
- Market cap
- USD 2.03B
- P/E
- 21.6x
- P/B
- 6.60x
- ROE
- 32.9%
- Dividend yield
- 1.77%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is EXETF.US undervalued?
Graham numberEXETF.US trades 151.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Extendicare Inc fundamental analysis
No fundamental analysis for Extendicare Inc yet.
Extendicare Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Extendicare Inc
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as w…
Full company profileExtendicare Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Extendicare Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.06B | 1.10B | 1.12B | 1.13B | 1.16B | 1.17B | 1.22B | 1.30B | 1.47B | 1.66B | 2.27B |
| Gross Profit | 130M | 104M | 98.5M | 93.7M | 198M | 116M | 76.8M | 168M | 1.47B | 199M | 290M |
| Operating Income | 57.7M | 66.2M | 38.8M | 52.4M | 93.3M | 63.2M | 21.0M | 112M | 111M | 138M | 222M |
| EBITDA | 98.2M | 102M | 75.2M | 90.3M | 127M | 75.2M | 49.5M | 98.6M | 155M | 175M | 257M |
| Net Income | 35.5M | 2.13M | 31.7M | 28.6M | 54.2M | 11.5M | 69.6M | 34.0M | 75.2M | 96.6M | 141M |
| EPS | 0.36 | 0.02 | 0.32 | 0.32 | 0.60 | 0.13 | 0.78 | 0.40 | 0.79 | 1.11 | 1.46 |
| Balance Sheet | |||||||||||
| Total Assets | 989M | 934M | 896M | 889M | 963M | 900M | 782M | 673M | 720M | 1.07B | 1.53B |
| Total Liabilities | 814M | 805M | 770M | 773M | 835M | 798M | 681M | 585M | 595M | 693M | 1.10B |
| Shareholders' Equity | 175M | 129M | 126M | 115M | 128M | 102M | 101M | 87.9M | 124M | 373M | 429M |
| Cash & Short-term Investments | 102M | 128M | 65.9M | 94.5M | 180M | 105M | 167M | 75.2M | 122M | 349M | 75.3M |
| Total Debt | 504M | 536M | 529M | 556M | 565M | 537M | 384M | 335M | 292M | 343M | 590M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -281K | 47.2M | 39.5M | 45.2M | 121M | 63.4M | 98.7M | 23.3M | 144M | 165M | 146M |
| Capital Expenditure | 38.8M | 41.1M | 50.6M | 33.2M | 33.1M | 69.5M | 102M | 129M | 42.0M | 102M | 36.2M |
| Free Cash Flow | -39.1M | 6.02M | -11.2M | 12.0M | 88.2M | -6.10M | -2.92M | -106M | 102M | 63.3M | 110M |
| Ratios | |||||||||||
| ROE | 20.3% | 1.7% | 25.2% | 24.8% | 42.3% | 11.3% | 69.1% | 38.7% | 60.5% | 25.9% | 32.9% |
| ROA | 3.6% | 0.2% | 3.5% | 3.2% | 5.6% | 1.3% | 8.9% | 5.1% | 10.4% | 9.1% | 9.2% |
| Net Profit Margin | 3.3% | 0.2% | 2.8% | 2.5% | 4.7% | 1.0% | 5.7% | 2.6% | 5.1% | 5.8% | 6.2% |
| Debt to Equity | 2.88x | 4.16x | 4.20x | 4.82x | 4.40x | 5.27x | 3.81x | 3.80x | 2.35x | 0.92x | 1.38x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Extendicare Inc dividends
- Dividend yield
- 1.77%
- Forward dividend
- 0.37 USD
- Payout ratio
- 43.1%
- Ex-dividend date
- Nov 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CAD 41.7M | 0.48 | 43.1% |
| 2024 | CAD 40.0M | 0.42 | 53.2% |
| 2023 | CAD 40.4M | 0.48 | 119.0% |
| 2022 | CAD 42.6M | 0.48 | 61.2% |
| 2021 | USD 43.0M | 0.48 | 373.7% |
| 2020 | USD 41.3M | 0.46 | 76.1% |
| 2019 | USD 37.2M | 0.42 | 130.0% |
| 2018 | USD 37.4M | 0.38 | 117.9% |
| 2017 | USD 37.5M | 0.37 | 1,759.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Extendicare Inc
- Insiders 0.48%
- Institutions 46.49%
- Public & others 53.03%
- Shares outstanding 95.0M
- Free float 93.9M
Extendicare Inc company profile
- Company name
- Extendicare Inc
- Ticker
- EXETF.US
- ISIN
- CA30224T8639
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- December
- Address
- 3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9
- Phone
- 905 470 4000
- Website
- extendicare.com
About Extendicare Inc
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
Extendicare Inc management
10- Dr. Michael R. Guerriere M.D., MBACEO, President & Director · born 1965
- Mr. David E. Bacon CPAExecutive VP & CFO
- Mr. Steve ParaskevopoulosSenior VP of ParaMed & CTO
- Mr. John ToffolettoSenior VP, Chief Legal Officer & Corporate Secretary
- Dr. Matthew MorganChief Medical Officer
- Mr. Joe BelinskyVP of Information Technology & Chief Information Officer
- Ms. Jillian E. Fountain CPAVice President of Investor Relations
- Ms. Danielle Labossiere ParrVice President of Public Affairs
- Ms. Kathryn Killoran BradleySenior Vice President of Corporate Development
- Ms. Katie LeMoyneSenior VP & Chief Human Resources Officer